Listed

Arcturus Therapeutics Holdings Inc.

ARCTNasdaqCIK 1768224HealthcareFiscal year ends Dec 31

Reports and events: 143 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arcturus Therapeutics Holdings Inc., Reports and events
FiledFormWhat it isAccession number
2023-07-1407:53 ET8-K7.01 Regulation FD disclosure0001193805-23-000984
2023-06-3008:28 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-23-000929
2023-06-1616:32 ET8-K5.07 Shareholder vote results0001193805-23-000861
2023-05-0916:36 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019773
2023-05-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-23-000686
2023-05-0116:32 ETDEF 14AProxy statementPeriod 2023-06-140001193805-23-000633
2023-04-2806:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-23-000619
2023-04-2117:21 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193805-23-000595
2023-04-1109:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-23-000532
2023-03-2918:33 ET10-KAnnual reportPeriod 2022-12-310000950170-23-010380
2023-03-2816:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-23-000401
2023-03-1716:15 ET8-K1.02 Termination of a material agreement0001193805-23-000356
2022-12-1316:14 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-22-001719
2022-12-1308:33 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-22-001712
2022-11-0916:55 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-023969
2022-11-0916:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-22-001504
2022-11-0417:00 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001193805-22-001480
2022-11-0218:36 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193805-22-001470
2022-09-0117:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193805-22-001230
2022-08-0916:08 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016043
2022-08-0916:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-22-001152
2022-06-2417:23 ET8-K1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193805-22-001014
2022-05-0916:31 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008524
2022-05-0916:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-22-000752
2022-05-0217:20 ETDEF 14AProxy statementPeriod 2022-06-210001193805-22-000731
2022-04-2017:24 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193805-22-000672
2022-03-0121:10 ET10-KAnnual reportPeriod 2021-12-310001564590-22-007832
2022-02-2816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-22-000402
2022-02-1707:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193805-22-000358
2022-02-1117:00 ET8-K5.02 Departure or appointment of officers or directors0001193805-22-000265
2022-01-1107:00 ET8-K7.01 Regulation FD disclosure0001193805-22-000036
2021-12-1317:17 ET8-K5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-21-001738
2021-11-1616:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193805-21-001584
2021-11-0919:10 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-055372
2021-11-0816:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193805-21-001541
2021-11-0116:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193805-21-001517
2021-10-0517:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193805-21-001417
2021-08-2616:15 ET8-K1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors0001193805-21-001224
2021-08-1017:39 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-042750
2021-08-0916:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-21-001134
2021-08-0416:15 ET8-K1.01 Entry into a material agreement0001193805-21-001100
2021-06-2216:31 ET8-K5.07 Shareholder vote results0001193805-21-000923
2021-05-1016:58 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-026113
2021-05-1016:21 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-21-000630
2021-04-3016:01 ETDEF 14AProxy statementPeriod 2021-06-180001193805-21-000583
2021-04-2617:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193805-21-000538
2021-03-0116:20 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193805-21-000289
2021-03-0116:18 ET10-KAnnual reportPeriod 2020-12-310001564590-21-009872
2021-02-2217:00 ET8-K3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193805-21-000256
2021-02-0313:00 ET8-K2.03 New direct financial obligation0001193805-21-000122

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 14:45 ET. Listed shows no prices and gives no investment advice.